WHO Proposes Swiss-Based Global Repository For Sharing Biological Samples Related To Disease Outbreak Threats 13/11/2020 Menaka Rao & Elaine Ruth Fletcher BREAKING – World Health Organization Director-General, Dr Tedros Adhanom Ghebreyesus has proposed the creation of a Swiss-based global repository for sharing pathogen materials and clinical samples related to potential outbreak threats – allowing for the more rapid development of medical interventions. The COVID-19 pandemic has shown the urgent need for this kind of system, said […] Continue reading -> Norway Ramps Up Efforts Against Non-Communicable Diseases in Low-income Countries 11/11/2020 Raisa Santos Norway will contribute an additional 133 million USD (1.2 billion NOK) to reduce the burden of non-communicable diseases (NCDs) in low-income countries from 2020 to 2024, the Ministry of International Development announced today. The announcement comes in the wake of last year’s path-blazing strategy for how to tackle the growing NCD burden in LMICs, “Better […] Continue reading -> World Health Assembly Debate On Improving Emergency Response – Warmup For Bigger Reforms? 10/11/2020 Elaine Ruth Fletcher The World Health Assembly on Tuesday approved a resolution calling to strengthen WHO and global preparedness for health emergencies – with few new teeth but lots of symbolism attached. The resolution makes a sweeping, but still largely ceremonial, call to countries and the WHO to reinvigorate systems of emergency preparedness, vulnerability assessment, alert, response, compliance […] Continue reading -> World Health Assembly Opens Against Shadows of Pandemic Despair & Hopes Incoming US Administration May Resume Global Health Leadership Role 08/11/2020 Elaine Ruth Fletcher & Madeleine Hoecklin This year’s 73rd edition of the World Health Assembly resumes virtually on Monday, after a two-day emergency huddle in May – against sharply rising COVID-19 infection rates in Europe and the United States, deep geopolitical divides – and calls for reform of the WHO that could strengthen its mandate but also may be resisted by […] Continue reading -> World Cities Day – Global Cooperation Amidst Pandemic Promotes Sustainable, Resilient Health 29/10/2020 Raisa Santos First in a Series: While COVID continues to cast a long shadow over our everyday lives, from Baku, Azerbaijan to Bogota, Columbia, there are also countless examples of how cities and communities have mobilized to respond to the social and economic fallout from the pandemic – building new forms of cooperation that also promote a […] Continue reading -> Digital Health, Drug Resistant Pathogens & Pandemic Preparedness: Keynote Topics At World Health Summit 27/10/2020 Madeleine Hoecklin At a time when the COVID-19 pandemic has exposed the fragility of health systems – digital health technologies are playing a fast-expanding role – showing their revolutionary potential to address old and new needs and gaps, said participants on a Digital Health panel at the World Health Summit on Monday. “COVID-19 is the first pandemic […] Continue reading -> Gilead Sciences Ignored WHO Evidence That Remdesivir Fails To Reduce COVID19 Mortality – In US FDA Submission For Drug’s Approval 23/10/2020 Elaine Ruth Fletcher The United States Food and Drug Administration decision Thursday to approve Gilead Science’s Remdesivir as a COVID-19 treatment failed to consider the results of the recent WHO “Solidarity Trial” – which found no measurable benefits for the drug’s use – because the pharma company failed to include the study in its FDA submission for approval, […] Continue reading -> Ratification of Africa Medicines Agency Treaty Inches Forward – Africa CDC Head Calls It ‘Much-Needed’ 16/10/2020 Paul Adepoju IBADAN, Nigeria – Nearly two years after the Assembly of the African Union, adopted a milestone treaty establishing an African Medicines Agency (AMA) that could provide a more unified approach to regulatory approval of new medicines and vaccines, the AMA treaty is yet to enter into force – because it has not been ratified by […] Continue reading -> The Indian/South African Proposal For a WTO Waiver On IP For COVID-19 Related Health Products – What It Means? 14/10/2020 Ellen 't Hoen A sweeping proposal by India and South Africa to suspend the protection of intellectual property (IP) related to COVID-19 health products is set to come before the The World Trade Organization’s TRIPS Council this week. The closed door discussion lays the groundwork for what could prove to be the most significant public debate over […] Continue reading -> Johnson & Johnson ‘Pauses’ COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment 13/10/2020 Editorial team Illustration of the AdVac® adenovirus technology, being tested by Johnson & Johnson, (Credit: J&J) Johnson & Johnson, the only pharma firm currently developing a one-dose COVID-19 vaccine candidate, has “paused” its Phase 3 clinical trial due to an unexplained illness in one of the participants. A press release issued on Monday confirmed reports that a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Norway Ramps Up Efforts Against Non-Communicable Diseases in Low-income Countries 11/11/2020 Raisa Santos Norway will contribute an additional 133 million USD (1.2 billion NOK) to reduce the burden of non-communicable diseases (NCDs) in low-income countries from 2020 to 2024, the Ministry of International Development announced today. The announcement comes in the wake of last year’s path-blazing strategy for how to tackle the growing NCD burden in LMICs, “Better […] Continue reading -> World Health Assembly Debate On Improving Emergency Response – Warmup For Bigger Reforms? 10/11/2020 Elaine Ruth Fletcher The World Health Assembly on Tuesday approved a resolution calling to strengthen WHO and global preparedness for health emergencies – with few new teeth but lots of symbolism attached. The resolution makes a sweeping, but still largely ceremonial, call to countries and the WHO to reinvigorate systems of emergency preparedness, vulnerability assessment, alert, response, compliance […] Continue reading -> World Health Assembly Opens Against Shadows of Pandemic Despair & Hopes Incoming US Administration May Resume Global Health Leadership Role 08/11/2020 Elaine Ruth Fletcher & Madeleine Hoecklin This year’s 73rd edition of the World Health Assembly resumes virtually on Monday, after a two-day emergency huddle in May – against sharply rising COVID-19 infection rates in Europe and the United States, deep geopolitical divides – and calls for reform of the WHO that could strengthen its mandate but also may be resisted by […] Continue reading -> World Cities Day – Global Cooperation Amidst Pandemic Promotes Sustainable, Resilient Health 29/10/2020 Raisa Santos First in a Series: While COVID continues to cast a long shadow over our everyday lives, from Baku, Azerbaijan to Bogota, Columbia, there are also countless examples of how cities and communities have mobilized to respond to the social and economic fallout from the pandemic – building new forms of cooperation that also promote a […] Continue reading -> Digital Health, Drug Resistant Pathogens & Pandemic Preparedness: Keynote Topics At World Health Summit 27/10/2020 Madeleine Hoecklin At a time when the COVID-19 pandemic has exposed the fragility of health systems – digital health technologies are playing a fast-expanding role – showing their revolutionary potential to address old and new needs and gaps, said participants on a Digital Health panel at the World Health Summit on Monday. “COVID-19 is the first pandemic […] Continue reading -> Gilead Sciences Ignored WHO Evidence That Remdesivir Fails To Reduce COVID19 Mortality – In US FDA Submission For Drug’s Approval 23/10/2020 Elaine Ruth Fletcher The United States Food and Drug Administration decision Thursday to approve Gilead Science’s Remdesivir as a COVID-19 treatment failed to consider the results of the recent WHO “Solidarity Trial” – which found no measurable benefits for the drug’s use – because the pharma company failed to include the study in its FDA submission for approval, […] Continue reading -> Ratification of Africa Medicines Agency Treaty Inches Forward – Africa CDC Head Calls It ‘Much-Needed’ 16/10/2020 Paul Adepoju IBADAN, Nigeria – Nearly two years after the Assembly of the African Union, adopted a milestone treaty establishing an African Medicines Agency (AMA) that could provide a more unified approach to regulatory approval of new medicines and vaccines, the AMA treaty is yet to enter into force – because it has not been ratified by […] Continue reading -> The Indian/South African Proposal For a WTO Waiver On IP For COVID-19 Related Health Products – What It Means? 14/10/2020 Ellen 't Hoen A sweeping proposal by India and South Africa to suspend the protection of intellectual property (IP) related to COVID-19 health products is set to come before the The World Trade Organization’s TRIPS Council this week. The closed door discussion lays the groundwork for what could prove to be the most significant public debate over […] Continue reading -> Johnson & Johnson ‘Pauses’ COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment 13/10/2020 Editorial team Illustration of the AdVac® adenovirus technology, being tested by Johnson & Johnson, (Credit: J&J) Johnson & Johnson, the only pharma firm currently developing a one-dose COVID-19 vaccine candidate, has “paused” its Phase 3 clinical trial due to an unexplained illness in one of the participants. A press release issued on Monday confirmed reports that a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
World Health Assembly Debate On Improving Emergency Response – Warmup For Bigger Reforms? 10/11/2020 Elaine Ruth Fletcher The World Health Assembly on Tuesday approved a resolution calling to strengthen WHO and global preparedness for health emergencies – with few new teeth but lots of symbolism attached. The resolution makes a sweeping, but still largely ceremonial, call to countries and the WHO to reinvigorate systems of emergency preparedness, vulnerability assessment, alert, response, compliance […] Continue reading -> World Health Assembly Opens Against Shadows of Pandemic Despair & Hopes Incoming US Administration May Resume Global Health Leadership Role 08/11/2020 Elaine Ruth Fletcher & Madeleine Hoecklin This year’s 73rd edition of the World Health Assembly resumes virtually on Monday, after a two-day emergency huddle in May – against sharply rising COVID-19 infection rates in Europe and the United States, deep geopolitical divides – and calls for reform of the WHO that could strengthen its mandate but also may be resisted by […] Continue reading -> World Cities Day – Global Cooperation Amidst Pandemic Promotes Sustainable, Resilient Health 29/10/2020 Raisa Santos First in a Series: While COVID continues to cast a long shadow over our everyday lives, from Baku, Azerbaijan to Bogota, Columbia, there are also countless examples of how cities and communities have mobilized to respond to the social and economic fallout from the pandemic – building new forms of cooperation that also promote a […] Continue reading -> Digital Health, Drug Resistant Pathogens & Pandemic Preparedness: Keynote Topics At World Health Summit 27/10/2020 Madeleine Hoecklin At a time when the COVID-19 pandemic has exposed the fragility of health systems – digital health technologies are playing a fast-expanding role – showing their revolutionary potential to address old and new needs and gaps, said participants on a Digital Health panel at the World Health Summit on Monday. “COVID-19 is the first pandemic […] Continue reading -> Gilead Sciences Ignored WHO Evidence That Remdesivir Fails To Reduce COVID19 Mortality – In US FDA Submission For Drug’s Approval 23/10/2020 Elaine Ruth Fletcher The United States Food and Drug Administration decision Thursday to approve Gilead Science’s Remdesivir as a COVID-19 treatment failed to consider the results of the recent WHO “Solidarity Trial” – which found no measurable benefits for the drug’s use – because the pharma company failed to include the study in its FDA submission for approval, […] Continue reading -> Ratification of Africa Medicines Agency Treaty Inches Forward – Africa CDC Head Calls It ‘Much-Needed’ 16/10/2020 Paul Adepoju IBADAN, Nigeria – Nearly two years after the Assembly of the African Union, adopted a milestone treaty establishing an African Medicines Agency (AMA) that could provide a more unified approach to regulatory approval of new medicines and vaccines, the AMA treaty is yet to enter into force – because it has not been ratified by […] Continue reading -> The Indian/South African Proposal For a WTO Waiver On IP For COVID-19 Related Health Products – What It Means? 14/10/2020 Ellen 't Hoen A sweeping proposal by India and South Africa to suspend the protection of intellectual property (IP) related to COVID-19 health products is set to come before the The World Trade Organization’s TRIPS Council this week. The closed door discussion lays the groundwork for what could prove to be the most significant public debate over […] Continue reading -> Johnson & Johnson ‘Pauses’ COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment 13/10/2020 Editorial team Illustration of the AdVac® adenovirus technology, being tested by Johnson & Johnson, (Credit: J&J) Johnson & Johnson, the only pharma firm currently developing a one-dose COVID-19 vaccine candidate, has “paused” its Phase 3 clinical trial due to an unexplained illness in one of the participants. A press release issued on Monday confirmed reports that a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
World Health Assembly Opens Against Shadows of Pandemic Despair & Hopes Incoming US Administration May Resume Global Health Leadership Role 08/11/2020 Elaine Ruth Fletcher & Madeleine Hoecklin This year’s 73rd edition of the World Health Assembly resumes virtually on Monday, after a two-day emergency huddle in May – against sharply rising COVID-19 infection rates in Europe and the United States, deep geopolitical divides – and calls for reform of the WHO that could strengthen its mandate but also may be resisted by […] Continue reading -> World Cities Day – Global Cooperation Amidst Pandemic Promotes Sustainable, Resilient Health 29/10/2020 Raisa Santos First in a Series: While COVID continues to cast a long shadow over our everyday lives, from Baku, Azerbaijan to Bogota, Columbia, there are also countless examples of how cities and communities have mobilized to respond to the social and economic fallout from the pandemic – building new forms of cooperation that also promote a […] Continue reading -> Digital Health, Drug Resistant Pathogens & Pandemic Preparedness: Keynote Topics At World Health Summit 27/10/2020 Madeleine Hoecklin At a time when the COVID-19 pandemic has exposed the fragility of health systems – digital health technologies are playing a fast-expanding role – showing their revolutionary potential to address old and new needs and gaps, said participants on a Digital Health panel at the World Health Summit on Monday. “COVID-19 is the first pandemic […] Continue reading -> Gilead Sciences Ignored WHO Evidence That Remdesivir Fails To Reduce COVID19 Mortality – In US FDA Submission For Drug’s Approval 23/10/2020 Elaine Ruth Fletcher The United States Food and Drug Administration decision Thursday to approve Gilead Science’s Remdesivir as a COVID-19 treatment failed to consider the results of the recent WHO “Solidarity Trial” – which found no measurable benefits for the drug’s use – because the pharma company failed to include the study in its FDA submission for approval, […] Continue reading -> Ratification of Africa Medicines Agency Treaty Inches Forward – Africa CDC Head Calls It ‘Much-Needed’ 16/10/2020 Paul Adepoju IBADAN, Nigeria – Nearly two years after the Assembly of the African Union, adopted a milestone treaty establishing an African Medicines Agency (AMA) that could provide a more unified approach to regulatory approval of new medicines and vaccines, the AMA treaty is yet to enter into force – because it has not been ratified by […] Continue reading -> The Indian/South African Proposal For a WTO Waiver On IP For COVID-19 Related Health Products – What It Means? 14/10/2020 Ellen 't Hoen A sweeping proposal by India and South Africa to suspend the protection of intellectual property (IP) related to COVID-19 health products is set to come before the The World Trade Organization’s TRIPS Council this week. The closed door discussion lays the groundwork for what could prove to be the most significant public debate over […] Continue reading -> Johnson & Johnson ‘Pauses’ COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment 13/10/2020 Editorial team Illustration of the AdVac® adenovirus technology, being tested by Johnson & Johnson, (Credit: J&J) Johnson & Johnson, the only pharma firm currently developing a one-dose COVID-19 vaccine candidate, has “paused” its Phase 3 clinical trial due to an unexplained illness in one of the participants. A press release issued on Monday confirmed reports that a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
World Cities Day – Global Cooperation Amidst Pandemic Promotes Sustainable, Resilient Health 29/10/2020 Raisa Santos First in a Series: While COVID continues to cast a long shadow over our everyday lives, from Baku, Azerbaijan to Bogota, Columbia, there are also countless examples of how cities and communities have mobilized to respond to the social and economic fallout from the pandemic – building new forms of cooperation that also promote a […] Continue reading -> Digital Health, Drug Resistant Pathogens & Pandemic Preparedness: Keynote Topics At World Health Summit 27/10/2020 Madeleine Hoecklin At a time when the COVID-19 pandemic has exposed the fragility of health systems – digital health technologies are playing a fast-expanding role – showing their revolutionary potential to address old and new needs and gaps, said participants on a Digital Health panel at the World Health Summit on Monday. “COVID-19 is the first pandemic […] Continue reading -> Gilead Sciences Ignored WHO Evidence That Remdesivir Fails To Reduce COVID19 Mortality – In US FDA Submission For Drug’s Approval 23/10/2020 Elaine Ruth Fletcher The United States Food and Drug Administration decision Thursday to approve Gilead Science’s Remdesivir as a COVID-19 treatment failed to consider the results of the recent WHO “Solidarity Trial” – which found no measurable benefits for the drug’s use – because the pharma company failed to include the study in its FDA submission for approval, […] Continue reading -> Ratification of Africa Medicines Agency Treaty Inches Forward – Africa CDC Head Calls It ‘Much-Needed’ 16/10/2020 Paul Adepoju IBADAN, Nigeria – Nearly two years after the Assembly of the African Union, adopted a milestone treaty establishing an African Medicines Agency (AMA) that could provide a more unified approach to regulatory approval of new medicines and vaccines, the AMA treaty is yet to enter into force – because it has not been ratified by […] Continue reading -> The Indian/South African Proposal For a WTO Waiver On IP For COVID-19 Related Health Products – What It Means? 14/10/2020 Ellen 't Hoen A sweeping proposal by India and South Africa to suspend the protection of intellectual property (IP) related to COVID-19 health products is set to come before the The World Trade Organization’s TRIPS Council this week. The closed door discussion lays the groundwork for what could prove to be the most significant public debate over […] Continue reading -> Johnson & Johnson ‘Pauses’ COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment 13/10/2020 Editorial team Illustration of the AdVac® adenovirus technology, being tested by Johnson & Johnson, (Credit: J&J) Johnson & Johnson, the only pharma firm currently developing a one-dose COVID-19 vaccine candidate, has “paused” its Phase 3 clinical trial due to an unexplained illness in one of the participants. A press release issued on Monday confirmed reports that a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Digital Health, Drug Resistant Pathogens & Pandemic Preparedness: Keynote Topics At World Health Summit 27/10/2020 Madeleine Hoecklin At a time when the COVID-19 pandemic has exposed the fragility of health systems – digital health technologies are playing a fast-expanding role – showing their revolutionary potential to address old and new needs and gaps, said participants on a Digital Health panel at the World Health Summit on Monday. “COVID-19 is the first pandemic […] Continue reading -> Gilead Sciences Ignored WHO Evidence That Remdesivir Fails To Reduce COVID19 Mortality – In US FDA Submission For Drug’s Approval 23/10/2020 Elaine Ruth Fletcher The United States Food and Drug Administration decision Thursday to approve Gilead Science’s Remdesivir as a COVID-19 treatment failed to consider the results of the recent WHO “Solidarity Trial” – which found no measurable benefits for the drug’s use – because the pharma company failed to include the study in its FDA submission for approval, […] Continue reading -> Ratification of Africa Medicines Agency Treaty Inches Forward – Africa CDC Head Calls It ‘Much-Needed’ 16/10/2020 Paul Adepoju IBADAN, Nigeria – Nearly two years after the Assembly of the African Union, adopted a milestone treaty establishing an African Medicines Agency (AMA) that could provide a more unified approach to regulatory approval of new medicines and vaccines, the AMA treaty is yet to enter into force – because it has not been ratified by […] Continue reading -> The Indian/South African Proposal For a WTO Waiver On IP For COVID-19 Related Health Products – What It Means? 14/10/2020 Ellen 't Hoen A sweeping proposal by India and South Africa to suspend the protection of intellectual property (IP) related to COVID-19 health products is set to come before the The World Trade Organization’s TRIPS Council this week. The closed door discussion lays the groundwork for what could prove to be the most significant public debate over […] Continue reading -> Johnson & Johnson ‘Pauses’ COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment 13/10/2020 Editorial team Illustration of the AdVac® adenovirus technology, being tested by Johnson & Johnson, (Credit: J&J) Johnson & Johnson, the only pharma firm currently developing a one-dose COVID-19 vaccine candidate, has “paused” its Phase 3 clinical trial due to an unexplained illness in one of the participants. A press release issued on Monday confirmed reports that a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Gilead Sciences Ignored WHO Evidence That Remdesivir Fails To Reduce COVID19 Mortality – In US FDA Submission For Drug’s Approval 23/10/2020 Elaine Ruth Fletcher The United States Food and Drug Administration decision Thursday to approve Gilead Science’s Remdesivir as a COVID-19 treatment failed to consider the results of the recent WHO “Solidarity Trial” – which found no measurable benefits for the drug’s use – because the pharma company failed to include the study in its FDA submission for approval, […] Continue reading -> Ratification of Africa Medicines Agency Treaty Inches Forward – Africa CDC Head Calls It ‘Much-Needed’ 16/10/2020 Paul Adepoju IBADAN, Nigeria – Nearly two years after the Assembly of the African Union, adopted a milestone treaty establishing an African Medicines Agency (AMA) that could provide a more unified approach to regulatory approval of new medicines and vaccines, the AMA treaty is yet to enter into force – because it has not been ratified by […] Continue reading -> The Indian/South African Proposal For a WTO Waiver On IP For COVID-19 Related Health Products – What It Means? 14/10/2020 Ellen 't Hoen A sweeping proposal by India and South Africa to suspend the protection of intellectual property (IP) related to COVID-19 health products is set to come before the The World Trade Organization’s TRIPS Council this week. The closed door discussion lays the groundwork for what could prove to be the most significant public debate over […] Continue reading -> Johnson & Johnson ‘Pauses’ COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment 13/10/2020 Editorial team Illustration of the AdVac® adenovirus technology, being tested by Johnson & Johnson, (Credit: J&J) Johnson & Johnson, the only pharma firm currently developing a one-dose COVID-19 vaccine candidate, has “paused” its Phase 3 clinical trial due to an unexplained illness in one of the participants. A press release issued on Monday confirmed reports that a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Ratification of Africa Medicines Agency Treaty Inches Forward – Africa CDC Head Calls It ‘Much-Needed’ 16/10/2020 Paul Adepoju IBADAN, Nigeria – Nearly two years after the Assembly of the African Union, adopted a milestone treaty establishing an African Medicines Agency (AMA) that could provide a more unified approach to regulatory approval of new medicines and vaccines, the AMA treaty is yet to enter into force – because it has not been ratified by […] Continue reading -> The Indian/South African Proposal For a WTO Waiver On IP For COVID-19 Related Health Products – What It Means? 14/10/2020 Ellen 't Hoen A sweeping proposal by India and South Africa to suspend the protection of intellectual property (IP) related to COVID-19 health products is set to come before the The World Trade Organization’s TRIPS Council this week. The closed door discussion lays the groundwork for what could prove to be the most significant public debate over […] Continue reading -> Johnson & Johnson ‘Pauses’ COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment 13/10/2020 Editorial team Illustration of the AdVac® adenovirus technology, being tested by Johnson & Johnson, (Credit: J&J) Johnson & Johnson, the only pharma firm currently developing a one-dose COVID-19 vaccine candidate, has “paused” its Phase 3 clinical trial due to an unexplained illness in one of the participants. A press release issued on Monday confirmed reports that a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
The Indian/South African Proposal For a WTO Waiver On IP For COVID-19 Related Health Products – What It Means? 14/10/2020 Ellen 't Hoen A sweeping proposal by India and South Africa to suspend the protection of intellectual property (IP) related to COVID-19 health products is set to come before the The World Trade Organization’s TRIPS Council this week. The closed door discussion lays the groundwork for what could prove to be the most significant public debate over […] Continue reading -> Johnson & Johnson ‘Pauses’ COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment 13/10/2020 Editorial team Illustration of the AdVac® adenovirus technology, being tested by Johnson & Johnson, (Credit: J&J) Johnson & Johnson, the only pharma firm currently developing a one-dose COVID-19 vaccine candidate, has “paused” its Phase 3 clinical trial due to an unexplained illness in one of the participants. A press release issued on Monday confirmed reports that a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Johnson & Johnson ‘Pauses’ COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment 13/10/2020 Editorial team Illustration of the AdVac® adenovirus technology, being tested by Johnson & Johnson, (Credit: J&J) Johnson & Johnson, the only pharma firm currently developing a one-dose COVID-19 vaccine candidate, has “paused” its Phase 3 clinical trial due to an unexplained illness in one of the participants. A press release issued on Monday confirmed reports that a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy